Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Caitlin Truesdale

Weekly Roundup – July 14, 2022 

View this email in your browser Weekly Roundup – July 14, 2022  Now in its 15th year, the Marcum LLP Tech Top 40 is the premier awards program...

| By Caitlin Truesdale

Study finds hospital adverse events decrease

The largest medical record-based study ever of adverse events suffered by hospitalized patients in the U.S. reports a significant decrease in the rate of such...

| By Caitlin Truesdale

Yale ‘blockchain’ offers control over genome

Blockchain is a digital technology that allows a secure and decentralized record of transactions that is increasingly used for everything from cryptocurrencies to artwork. But...

| By Caitlin Truesdale

Ireland’s Nuritas chooses New Haven HQ location

Ireland-based Nuritas is establishing its North American headquarters in New Haven. The move is evidence of the growing appeal of the Elm City’s thriving bioscience ecosystem. Nuritas...

| By Caitlin Truesdale

Developers to spend $300 million on Science Park

Science Park is an 80-acre swath of former industrial land in the central Newhallville neighborhood of New Haven. Evolving over the decades from factories to industrial...

| By Caitlin Truesdale

Boehringer and allies to build anti-superbug startup

Boehringer Ingelheim is pumping 30 million euros ($31 million) into the fight against drug-resistant bacteria. Working with Evotec and bioMérieux, the German drugmaker has set up...

| By Caitlin Truesdale

Weekly Roundup – July 7, 2022 

View this email in your browser Weekly Roundup – July 7, 2022  Michael Kasdan, Partner at Wiggin and Dana, recently published an article The Patent vs Trade...

| By Caitlin Truesdale

Trevi reports positive results in skin condition trial

New Haven-based Trevi Therapeutics has reported positive results in a trial of its drug Haduvio for treatment of prurigo nodularis, a chronic inflammatory skin disease. Trevi CEO...

| By Caitlin Truesdale

Artizan Biosciences leases at Winchester Works

Artizan Biosciences has inked a lease to occupy 10,000 square feet of Class A laboratory and office space at Winchester Works in New Haven. The New...

| By Caitlin Truesdale

FDA targets neurodegenerative diseases

There’s an urgent need to improve and extend the lives of patients with rare neurodegenerative diseases, and the FDA is hoping a new five-year action...